Analysts at Bank of America just made the bull case for Texas Instruments (NASDAQ:TXN | TXN Price Prediction), with analyst Vivek Arya upgrading the chipmaker to Buy from Neutral and lifting his price target to $320 from $235. The call arrives one day after a blockbuster Q1 print, and it’s far from the only vote of confidence hitting the tape. For long-term investors, the revised outlook reframes Texas Instruments stock as a stealth industrial AI play with analog roots.
The upgrade reflects conviction that Texas Instruments’ multi-year U.S. fab buildout is finally paying off in a supply-constrained chip cycle. BofA raised its CY2026, 2027, and 2028 GAAP EPS forecasts by 21%, 31%, and 33%, respectively, signaling the firm sees durable earnings power ahead.
| Ticker | Company | Firm | Action | Old Rating | New Rating | Old Target | New Target |
|---|---|---|---|---|---|---|---|
| TXN | Texas Instruments | BofA | Upgrade | Neutral | Buy | $235 | $320 |
The Analyst’s Case
Arya cited Texas Instruments’ “solid” Q1 report and Q2 guidance, confidence in an industrial resurgence, a data-center build advantage, and leverage from three years of capex in U.S. fabs in an “everything-is-constrained” chip environment. That framing positions Texas Instruments as a primary beneficiary of both reshoring and AI infrastructure demand.
BofA isn’t alone. On the same day, JPMorgan lifted its TXN stock price target to $280 from $227, KeyBanc moved to $325 from $240, Benchmark to $315 from $250, and Jefferies to $260 from $210. Barclays upgraded from Underweight to Equal Weight with a $250 target, while Goldman stayed at Sell with a $200 target, providing a rare dissenting voice.
Company Snapshot
Texas Instruments is a global analog and embedded processing chipmaker led by CEO Haviv Ilan, with a market cap of $254.37 billion. Q1 FY2026 revenue hit $4.83 billion, up 19% year over year, with EPS of $1.68 against a $1.36 estimate.
The Analog segment delivered $3.92 billion in revenue, up 22%, while industrial grew 20% sequentially and 30% year over year, and data center expanded 25% sequentially and 90% year over year. Free cash flow swung to $1.4 billion, aided by $555 million in CHIPS Act proceeds.
Why the Move Matters Now
Texas Instruments’ management guided Q2 revenue to $5 billion to $5.4 billion with EPS of $1.77 to $2.05, confirming momentum is accelerating. Ilan told investors, “Revenue increased 9% sequentially and 19% from the same quarter a year ago with growth led by industrial and data center.”
Texas Instruments trades at a P/E ratio of 43x, a premium multiple that demands continued execution. For context on the broader semiconductor cycle, see our recent coverage of analyst coverage updates.
What It Means for Your Portfolio
The chorus of price target raises validates that Texas Instruments has re-rated into an industrial AI beneficiary with a rare domestic manufacturing moat. Yet the Goldman Sell rating and cyclical industrial exposure argue against chasing the stock aggressively after a sharp rally.
For retirement-focused investors, TXN stock offers a defensible dividend (Q1 declared at $1.42 per share) and exposure to reshoring tailwinds. A moderate position, scaled in over time, may be prudent without overpaying at current levels.
Watch for whether Q2 results confirm industrial and data center acceleration. If growth holds, BofA’s revised earnings trajectory could prove conservative.
Top Gaining Stocks
Top Losing Stocks